Skip to content

A study on complications and prognosis in blood purification therapy

A study on complications and prognosis in blood purification therapy - A study on complications and prognosis in blood purification therapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000033627
Enrollment
1000
Registered
2018-08-06
Start date
2018-06-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases to be indicated for blood purification therapy

Interventions

None listed

Sponsors

Tokyo Women's Medical University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male and female 20 years old or older 2. Patients who underwent blood purification therapy at our hospital

Exclusion criteria

Exclusion criteria: 1. Children under the age of 20 2. Patients whom research managers judged inappropriate as study subjects

Design outcomes

Primary

MeasureTime frame
Prognosis

Secondary

MeasureTime frame
Complications

Countries

Japan

Contacts

Public ContactNobue Tanaka

Tokyo Women's Medical University School of Medicine Department of Blood Purification Therapy

nobuetan.dmc@twmu.ac.jp03-3353-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026